Agios Pharmaceuticals AGIO Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's capital investments accrued but not yet paid?
- Agios Pharmaceuticals (AGIO) reported capital investments accrued but not yet paid of $668K in Q1 2026.
- How has Agios Pharmaceuticals's capital investments accrued but not yet paid changed year-over-year?
- Agios Pharmaceuticals's capital investments accrued but not yet paid increased by 202.3% year-over-year, from $221K to $668K.
- What is the long-term trend for Agios Pharmaceuticals's capital investments accrued but not yet paid?
- Over 2 years (2021 to 2024), Agios Pharmaceuticals's capital investments accrued but not yet paid has grown at a -56.5% compound annual growth rate (CAGR), from $1.68M to $317K.